We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment.
- Authors
Andreotti, Felicita; O'Donoghue, Michelle L; Berg, Jurriën M Ten
- Abstract
This article provides a summary of recent pivotal papers on thrombosis and antithrombotic treatment in cardiovascular medicine. The article discusses various topics, including the use of bivalirudin in percutaneous coronary intervention (PCI), the optimization of P2Y12-inhibitor choice in acute coronary syndrome (ACS) patients, the duration of dual antiplatelet therapy (DAPT) in high-bleeding risk patients, the comparison of clopidogrel and aspirin post-PCI, the role of coagulation factor XI in atrial fibrillation (AF), the use of oral anticoagulants (OAC) in AF patients with low-stroke risk, the use of OAC in subclinical AF, the use of aspirin and unfractionated heparin (UFH) in acute ischemic stroke, and the optimal antithrombotic therapy in patients undergoing transcatheter aortic valve implantation (TAVI). The article provides a balanced overview of the findings from these studies, highlighting both the benefits and limitations of each approach.
- Subjects
MYOCARDIAL infarction; ST elevation myocardial infarction; TRANSIENT ischemic attack; THROMBOSIS
- Publication
European Heart Journal, 2024, Vol 45, Issue 19, p1727
- ISSN
0195-668X
- Publication type
Article
- DOI
10.1093/eurheartj/ehae123